These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


867 related items for PubMed ID: 8567969

  • 1. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM.
    J Clin Invest; 1996 Jan 15; 97(2):469-76. PubMed ID: 8567969
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H, King GL, Ferrara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 1996 Jun 15; 37(7):1311-21. PubMed ID: 8641834
    [Abstract] [Full Text] [Related]

  • 3. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A, Koren B, Cohen T, Neufeld G, Kleinberger T, Lewis BS, Flugelman MY.
    Circulation; 2001 Apr 10; 103(14):1887-92. PubMed ID: 11294808
    [Abstract] [Full Text] [Related]

  • 4. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF, Tognazzi K, Dvorak HF, Harrist TJ.
    Am J Pathol; 1996 Apr 10; 148(4):1065-74. PubMed ID: 8644848
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T.
    J Mol Cell Cardiol; 1999 Mar 10; 31(3):607-17. PubMed ID: 10198191
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.
    Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP.
    J Invest Dermatol; 1997 Mar 10; 108(3):263-8. PubMed ID: 9036922
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, Zioncheck TF.
    J Biol Chem; 1998 Nov 06; 273(45):29979-85. PubMed ID: 9792718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
    Kremer C, Breier G, Risau W, Plate KH.
    Cancer Res; 1997 Sep 01; 57(17):3852-9. PubMed ID: 9288799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia.
    Waltenberger J, Mayr U, Pentz S, Hombach V.
    Circulation; 1996 Oct 01; 94(7):1647-54. PubMed ID: 8840857
    [Abstract] [Full Text] [Related]

  • 13. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 01; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML.
    J Biol Chem; 1996 Feb 09; 271(6):3154-62. PubMed ID: 8621715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 09; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.